Life Cycle Assessment

Widheden, Johan; Ringström, Emma

doi:10.1016/b978-044451664-0/50021-8

Cited by 6 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmaceutical companies are increasingly seeking suppliers who adhere to responsible environmental and social practices. This includes sourcing from environmentally certified suppliers, promoting fair trade and labor practices, and considering the ecological and social impact of raw material extraction [64].…”

Section: Overview Of Sustainable Manufacturing Practicesmentioning

confidence: 99%

“…Sustainable sourcing of raw materials, managing waste streams, and monitoring social and environmental practices of suppliers can be complex and require collaboration and transparency across the supply chain. Establishing robust sustainability criteria and implementing effective supply chain management systems are necessary to address these challenges [64,77]. Despite increasing interest in sustainability, awareness, and education about sustainable practices in drug manufacturing remain relatively limited.…”

Section: Current Challenges In Drug Manufacturing Sustainabilitymentioning

confidence: 99%

See 1 more Smart Citation

Seaweed: a sustainable solution for greening drug manufacturing in the pursuit of sustainable healthcare

Pereira,

Cotas

2024

Explor Drug Sci

View full text Add to dashboard Cite

The environmental impact of drug manufacturing raises concerns about sustainability in healthcare. To address this, exploring alternative approaches to drug production is crucial. This review focuses on seaweed as a sustainable resource for greening drug manufacturing processes. Seaweed offers advantages such as renewability, abundance, and a positive environmental footprint. The review begins by providing an overview of sustainable drug manufacturing practices and the challenges faced in achieving sustainability. It then discusses seaweed as a sustainable resource, including cultivation techniques and environmental benefits. Seaweed has various applications in drug manufacturing, including extracting and purifying bioactive compounds with potential therapeutic properties. Seaweed’s role in developing green technologies, such as seaweed-based excipients, biodegradable packaging materials, and as a source of sustainable energy for drug manufacturing processes, is highlighted. The environmental and economic implications of incorporating seaweed-based solutions are discussed, emphasizing reduced carbon footprint and cost-effectiveness. Regulatory and industrial perspectives are addressed, examining challenges, and opportunities for implementing seaweed-based drug manufacturing. Collaboration between academia, industry, and regulatory bodies is crucial for successful integration. The review presents future directions and opportunities, including emerging trends and innovations in seaweed-based drug manufacturing, areas for further research, policy development, and industry engagement recommendations. Incorporating seaweed into drug production facilitates a reduction in environmental impact, promotes resource efficiency, and contributes to sustainable healthcare. This review showcases seaweed-based solutions as a means to foster a greener future for drug manufacturing, addressing environmental concerns, and promoting sustainability.

show abstract

Section: Overview Of Sustainable Manufacturing Practicesmentioning

confidence: 99%

Section: Current Challenges In Drug Manufacturing Sustainabilitymentioning

confidence: 99%